Synopsys [SNPS] vs Oracle [ORCL] Detailed Stock Comparison

Synopsys

NASDAQ
Loading...

Oracle

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Synopsys wins in 12 metrics, Oracle wins in 7 metrics, with 0 ties. Synopsys appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSynopsysOracleBetter
P/E Ratio (TTM)57.4967.63Synopsys
Price-to-Book Ratio2.8633.48Synopsys
Debt-to-Equity Ratio54.83427.35Synopsys
PEG Ratio-1.3340.81Synopsys
EV/EBITDA69.8437.64Oracle
Profit Margin (TTM)31.04%21.08%Synopsys
Operating Margin (TTM)9.50%31.44%Oracle
EBITDA Margin (TTM)9.50%31.44%Oracle
Return on Equity6.50%69.24%Oracle
Return on Assets (TTM)2.31%7.15%Oracle
Free Cash Flow (TTM)$1.28B$-394.00MSynopsys
Dividend YieldN/A0.81%N/A
1-Year Return-13.19%80.32%Oracle
Price-to-Sales Ratio (TTM)12.2814.07Synopsys
Enterprise Value$91.57B$920.10BOracle
EV/Revenue Ratio14.2315.59Synopsys
Gross Profit Margin (TTM)78.13%70.19%Synopsys
Revenue per Share (TTM)$41$21Synopsys
Earnings per Share (Diluted)$7.40$4.32Synopsys
Beta (Stock Volatility)1.141.46Synopsys
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Synopsys vs Oracle Stock Performance Analysis

Loading Price Chart...

Synopsys
Oracle
Synopsys Stock Overview | Oracle Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Synopsys-2.89%-28.87%-32.02%-14.05%-1.62%-11.87%
Oracle-5.09%25.51%15.09%46.19%93.64%75.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Synopsys-13.19%35.40%114.95%798.90%1,644.36%2,184.91%
Oracle80.32%324.50%389.00%703.13%963.25%2,105.13%

News Based Sentiment: Synopsys vs Oracle

Synopsys

News based Sentiment: NEGATIVE

Synopsys experienced a significant setback in September with a substantial earnings miss, lowered guidance, and a dramatic stock price decline. While the company continues to invest in promising areas like AI, the near-term challenges and negative market reaction make this a pivotal moment for the company and its investors.

View Synopsys News Sentiment Analysis

Oracle

News based Sentiment: POSITIVE

Oracle’s Q1 FY26 results, coupled with the massive $300 billion OpenAI contract and exceptionally strong cloud revenue projections, represent a significant turning point for the company. The surge in stock price and positive spillover to other AI-related stocks demonstrate the market’s enthusiastic response to Oracle’s strategic positioning in the AI infrastructure space.

View Oracle News Sentiment Analysis

Performance & Financial Health Analysis: Synopsys vs Oracle

MetricSNPSORCL
Market Information
Market Cap i$79.03B$822.34B
Market Cap CategoryLarge capMega cap
10 Day Avg. Volume i5,284,96037,489,340
90 Day Avg. Volume i2,461,24719,222,627
Last Close$425.45$292.18
52 Week Range$365.74 - $651.73$118.86 - $345.72
% from 52W High-34.72%-15.49%
All-Time High$651.72 (Jul 30, 2025)$345.72 (Sep 10, 2025)
% from All-Time High-34.72%-15.49%
Growth Metrics
Quarterly Revenue Growth0.14%0.12%
Quarterly Earnings Growth-0.41%0.00%
Financial Health
Profit Margin (TTM) i0.31%0.21%
Operating Margin (TTM) i0.10%0.31%
Return on Equity (TTM) i0.07%0.69%
Debt to Equity (MRQ) i54.83427.35
Cash & Liquidity
Book Value per Share (MRQ)$148.90$8.73
Cash per Share (MRQ)$13.96$3.89
Operating Cash Flow (TTM) i$1.44B$21.53B
Levered Free Cash Flow (TTM) i$2.63B$-304,249,984
Dividends
Last 12-Month Dividend Yield iN/A0.81%
Last 12-Month Dividend iN/A$1.70

Valuation & Enterprise Metrics Analysis: Synopsys vs Oracle

MetricSNPSORCL
Price Ratios
P/E Ratio (TTM) i57.4967.63
Forward P/E i28.6140.81
PEG Ratio i-1.3340.81
Price to Sales (TTM) i12.2814.07
Price to Book (MRQ) i2.8633.48
Market Capitalization
Market Capitalization i$79.03B$822.34B
Enterprise Value i$91.57B$920.10B
Enterprise Value Metrics
Enterprise to Revenue i14.2315.59
Enterprise to EBITDA i69.8437.64
Risk & Other Metrics
Beta i1.141.46
Book Value per Share (MRQ) i$148.90$8.73

Financial Statements Comparison: Synopsys vs Oracle

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SNPSORCL
Revenue/Sales i$1.60B$15.90B
Cost of Goods Sold i$318.35M$4.74B
Gross Profit i$1.29B$11.16B
Research & Development i$553.98M$2.65B
Operating Income (EBIT) i$376.43M$5.19B
EBITDA i$490.66M$7.00B
Pre-Tax Income i$396.19M$4.15B
Income Tax i$47.18M$725.00M
Net Income (Profit) i$345.11M$3.43B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SNPSORCL
Cash & Equivalents i$14.12B$10.79B
Total Current Assets i$16.88B$24.58B
Total Current Liabilities i$2.41B$32.64B
Long-Term Debt i$10.62B$96.83B
Total Shareholders Equity i$9.92B$20.97B
Retained Earnings i$9.62B$-15.48B
Property, Plant & Equipment i$1.16B$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SNPSORCL
Operating Cash Flow i$275.78M$5.93B
Capital Expenditures i$18.69MN/A
Free Cash Flow i$219.78M$-2.92B
Debt Repayment i$0$-6.07B
Common Stock Repurchase iN/A$-150.00M

Short Interest & Institutional Ownership Analysis

MetricSNPSORCL
Shares Short i3.24M21.48M
Short Ratio i2.742.06
Short % of Float i0.02%0.01%
Average Daily Volume (10 Day) i5,284,96037,489,340
Average Daily Volume (90 Day) i2,461,24719,222,627
Shares Outstanding i154.11M2.81B
Float Shares i184.68M1.65B
% Held by Insiders i0.00%0.41%
% Held by Institutions i0.81%0.45%

Dividend Analysis & Yield Comparison: Synopsys vs Oracle

MetricSNPSORCL
Last 12-Month Dividend iN/A$1.70
Last 12-Month Dividend Yield iN/A0.81%
3-Year Avg Annual Dividend iN/A$1.55
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A$4.66
Ex-Dividend DateN/AApr 10, 2025